Human Longevity and Performance Impact Venture Fund Asset Manager Profile - aVenture Research
Human Longevity and Performance Impact Venture Fund is a longevity focused early-stage venture capital fund dedicated to providing resources, insight, and leadership to companies whose mission is to improve human health and drive longevity through technology, predictive analytics, research, and patient care.
HLPIVF is establishing a synergistic ecosystem of longevity and performance-focused companies to dramatically increase the volume and effectiveness of life-affirming diagnostics and therapeutics.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Recorded Recipients1
Operating Recipients1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of recorded participations by stage.